Chemify, a Glasgow, Scotland, UK-based deep tech chemical science company, has been awarded a grant from the Bill & Melinda Gates Foundation to discover new drug leads for treating tuberculosis (TB) and malaria.
By leveraging the company’s proprietary Chemputation technology and workflow, Chemify aims to deliver drug design and discovery outcomes and potential drug candidates to positively impact the lives of patients worldwide.
Led by Dr. Lee Cronin, CEO, Chemify is a deep tech chemical science company that combines chemistry, robotics and AI at scale to digitally design, discover and make new molecules. The company will design, make, and discover compounds using its Chemputation technology – an automated, seamlessly-controlled digital chemical stack with cheminformatics, robotics and AI to connect the digital design, planning and multiplexed synthesis of novel small molecules. Potential leads will be iteratively optimized using the Chemputation-driven AI during each development cycle. Lead compounds will then be further analyzed and developed by undisclosed partners.
Chemify was founded by CEO Professor Lee Cronin and spun out from the Digital Chemistry Laboratory at the University of Glasgow to digitalize chemistry on a global scale for the benefit of all humanity.
FinSMEs
01/10/2024